SYP and adenocarcinoma: Expression of synaptophysin was observed in nine of 29 (31%) adenocarcinomas, and of these the marker was expressed in three of ten (30%) intestinal type adenocarcinomas, four of 15 (27%) diffuse type adenocarcinomas, and two of four (50%) mixed/indeterminate type adenocarcinomas.